Back to Search Start Over

Modulation of Leishmania donovani infection and cell viability by testosterone in bone marrow-derived macrophages: Signaling via surface binding sites

Authors :
Liu, Limin
Benten, W. Peter M.
Wang, Lianyun
Hao, Xiangfang
Li, Qiaoli
Zhang, Huaping
Guo, Dongxing
Wang, Yajing
Wunderlich, Frank
Qiao, Zhongdong
Source :
Steroids. Aug2005, Vol. 70 Issue 9, p604-614. 11p.
Publication Year :
2005

Abstract

Abstract: Androgens can increase susceptibility toward numerous parasitic infections as well as modulate apoptosis of immune cells. According to the current view, androgens mediate immune cell activities not only through classical intracellular androgen receptors (AR), but also through membrane receptors on the cell surface. Here, using murine bone marrow-derived macrophages (BMMs), we examined the influence of testosterone on Leishmania donovani infection and cell viability in vitro as well as the possible mechanisms. Our data demonstrated that testosterone directly increased intramacrophage infection by L. donovani. In addition, testosterone decreased cell viability by way of apoptosis, accompanied by increased Fas, FasL, and Caspase-8 expression. However, these effects of testosterone could not be associated with the classical AR in BMMs since AR was not detectable using different experimental techniques. Instead, it was found that testosterone could bind to the surface of BMMs by the use of an impermeable testosterone-BSA-FITC in confocal laser scanning microscopy and flow cytometry. Collectively, our data indicated that the influence of testosterone on L. donovani infection and viability of BMMs was mediated through the binding sites of testosterone on cell surfaces, which provided a novel mode of direct action of testosterone on AR-free BMMs. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
0039128X
Volume :
70
Issue :
9
Database :
Academic Search Index
Journal :
Steroids
Publication Type :
Academic Journal
Accession number :
18106688
Full Text :
https://doi.org/10.1016/j.steroids.2005.02.020